PC
ELV icon

Pecaut & Co’s Elevance Health ELV Stock Holding History

Pecaut & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$233K – 83
2025
Q2 		$233K Hold
600
– – 0.08% 74
2025
Q1 		$261K Sell
600
-100
-14% -$40.1K 0.09% 66
2024
Q4 		$258K Buy
+700
New +$293K 0.09% 65
2023
Q2 		– Sell
-450
Closed -$207K – 111
2023
Q1 		$207K Hold
450
– – 0.09% 76
2022
Q4 		$231K Hold
450
– – 0.11% 75
2022
Q3 		$204K Hold
450
– – 0.11% 72
2022
Q2 		$217K Hold
450
– – 0.12% 72
2022
Q1 		$221K Hold
450
– – 0.11% 71
2021
Q4 		$209K Buy
+450
New +$189K 0.11% 67

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Pecaut & Co's ELV Position: Q3 2025 in Review

Pecaut & Co sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 600 shares — an estimated $233K sold.

Pecaut & Co first reported a position in ELV in Q4 2021 and held it in 9 quarters. The position peaked at $261K in Q1 2025. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Pecaut & Co reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Pecaut & Co sold 600 Elevance Health shares in Q3 2025, an estimated $233K.
  • Pecaut & Co first reported a position in Elevance Health in Q4 2021 and held it in 9 quarters.
  • Pecaut & Co's Elevance Health position peaked at $261K in Q1 2025.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Pecaut & Co's 13F filing for Q3 2025, filed 3 Nov 2025.